Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Good_Start_Genetics
gptkb:CombiMatrix gptkb:Genelex gptkb:Singular_Bio |
| gptkbp:CEO |
gptkb:Ken_Knight
|
| gptkbp:founded |
2010
|
| gptkbp:founder |
gptkb:Randy_Scott
|
| gptkbp:headquartersLocation |
gptkb:San_Francisco,_California,_United_States
|
| gptkbp:industry |
Genetic testing
|
| gptkbp:listedOn |
gptkb:NYSE
|
| gptkbp:mission |
To bring comprehensive genetic information into mainstream medicine to improve healthcare for everyone.
|
| gptkbp:numberOfEmployees |
over 1,500 (as of 2022)
|
| gptkbp:product |
Cancer screening
Prenatal testing Carrier screening Genetic tests for inherited conditions Pharmacogenomics testing |
| gptkbp:publiclyTraded |
Yes
|
| gptkbp:specializesIn |
Medical genetics
Genetic diagnostics |
| gptkbp:stockSymbol |
gptkb:NVTA
|
| gptkbp:tradedOn |
gptkb:New_York_Stock_Exchange
|
| gptkbp:website |
https://www.invitae.com/
|
| gptkbp:bfsParent |
gptkb:Gregory_T._Lucier
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
InVitae
|